Table 1 Comparison of the baseline data of patient with and without MHE
None | MHE | p | ||
|---|---|---|---|---|
N = 91 (35.4%) | N = 166 (64.6%) | |||
Age (years) | 50.42 ± 7.92 | 54.61 ± 8.30 | 0.001 | |
Sex | Female | 46 (50.5%) | 90 (54.2%) | 0.603 |
Male | 45 (49.5%) | 76 (45.8%) | ||
Total bilirubin (mg/dL) | 0.88 ± 0.25 | 1.14 ± 0.73 | 0.017# | |
Direct bilirubin (mg/dL) | 0.35 ± 0.14 | 0.53 ± 0.48 | 0.002# | |
Albumin (g/dL) | 3.83 ± 0.42 | 3.46 ± 0.52 | 0.001# | |
AST (U/L) | 42.54 ± 22.03 | 45.26 ± 20.74 | 0.061# | |
ALT (U/L) | 34.80 ± 20.12 | 36.81 ± 15.68 | 0.391 | |
Hemoglobin (g/dL) | 11.97 ± 1.48 | 11.66 ± 1.51 | 0.160# | |
WBCs (×103/μL) | 5.70 ± 1.36 | 5.30 ± 1.30 | 0.028 | |
Platelets (×103/μL) | 122.37 ± 40.49 | 123.04 ± 71.83 | 0.515# | |
INR | 1.18 ± 0.14 | 1.34 ± 0.28 | 0.001# | |
Ammonia μmol/L | 63.56 ± 24.20 | 86.59 ± 23.25 | 0.001 | |
CTP score | 5.25 ± 0.70 | 6.15 ± 1.62 | 0.001# | |
CTP class | A | 86 (43.2%) | 113 (56.8%) | 0.001 |
B | 5 (10%) | 45 (90%) | ||
C | 0 (0%) | 8 (100%) | ||
MELD | 8.46 ± 3.06 | 10.78 ± 4.01 | 0.001# | |
ALBI score | −2.49 ± 0.38 | −2.13 ± 0.53 | 0.001# | |
ALBI class | ALBI 1 | 18 (66.7%) | 9 (33.3%) | 0.001 |
ALBI 2 | 72 (34.1%) | 139 (65.9%) | ||
ALBI 3 | 1 (5.3%) | 18 (94.7%) | ||
PALBI score | −2.55 ± 0.26 | −2.33 ± 0.39 | 0.001 | |
ALBI-PLT score | 3.70 ± 0.56 | 3.98 ± 0.49 | 0.001# | |